Global Antiasthmatic Drug Supply, Demand and Key Producers, 2024-2030
Page: 171
Published Date: 11 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Antiasthmatic Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Antiasthmatic drugs refer to the drugs that can eliminate chronic airway inflammation, relieve bronchoconstriction and spasm, dilate bronchus and reduce airway hyperresponsiveness.
This report studies the global Antiasthmatic Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antiasthmatic Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiasthmatic Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antiasthmatic Drug total market, 2019-2030, (USD Million)
Global Antiasthmatic Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Antiasthmatic Drug total market, key domestic companies and share, (USD Million)
Global Antiasthmatic Drug revenue by player and market share 2019-2024, (USD Million)
Global Antiasthmatic Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Antiasthmatic Drug total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Antiasthmatic Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited and Chiesi GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiasthmatic Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Antiasthmatic Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Antiasthmatic Drug Market, Segmentation by Type
Bronchodilators
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic
Global Antiasthmatic Drug Market, Segmentation by Application
Hospital
Clinic
Other
Companies Profiled:
Novartis AG
GlaxoSmithKline
ABC Farmaceutici Spa
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi GmbH
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Ruiyang Pharmaceutical Co., Ltd
Fuhe Group
Lunan Pharmaceutical Group Co., Ltd
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH&Co.KG
Covis Pharmaceutical Inc
Roche
Key Questions Answered
1. How big is the global Antiasthmatic Drug market?
2. What is the demand of the global Antiasthmatic Drug market?
3. What is the year over year growth of the global Antiasthmatic Drug market?
4. What is the total value of the global Antiasthmatic Drug market?
5. Who are the major players in the global Antiasthmatic Drug market?
Table of Contents
1 Supply Summary
1.1 Antiasthmatic Drug Introduction
1.2 World Antiasthmatic Drug Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Antiasthmatic Drug Total Market by Region (by Headquarter Location)
1.3.1 World Antiasthmatic Drug Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Antiasthmatic Drug Market Size (2019-2030)
1.3.3 China Antiasthmatic Drug Market Size (2019-2030)
1.3.4 Europe Antiasthmatic Drug Market Size (2019-2030)
1.3.5 Japan Antiasthmatic Drug Market Size (2019-2030)
1.3.6 South Korea Antiasthmatic Drug Market Size (2019-2030)
1.3.7 ASEAN Antiasthmatic Drug Market Size (2019-2030)
1.3.8 India Antiasthmatic Drug Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiasthmatic Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antiasthmatic Drug Major Market Trends
2.1 World Antiasthmatic Drug Consumption Value (2019-2030)
2.2 World Antiasthmatic Drug Consumption Value by Region
2.2.1 World Antiasthmatic Drug Consumption Value by Region (2019-2024)
2.2.2 World Antiasthmatic Drug Consumption Value Forecast by Region (2025-2030)
2.3 United States Antiasthmatic Drug Consumption Value (2019-2030)
2.4 China Antiasthmatic Drug Consumption Value (2019-2030)
2.5 Europe Antiasthmatic Drug Consumption Value (2019-2030)
2.6 Japan Antiasthmatic Drug Consumption Value (2019-2030)
2.7 South Korea Antiasthmatic Drug Consumption Value (2019-2030)
2.8 ASEAN Antiasthmatic Drug Consumption Value (2019-2030)
2.9 India Antiasthmatic Drug Consumption Value (2019-2030)
3.1 World Antiasthmatic Drug Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antiasthmatic Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antiasthmatic Drug in 2023
3.2.3 Global Concentration Ratios (CR8) for Antiasthmatic Drug in 2023
3.3 Antiasthmatic Drug Company Evaluation Quadrant
3.4 Antiasthmatic Drug Market: Overall Company Footprint Analysis
3.4.1 Antiasthmatic Drug Market: Region Footprint
3.4.2 Antiasthmatic Drug Market: Company Product Type Footprint
3.4.3 Antiasthmatic Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Antiasthmatic Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antiasthmatic Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Antiasthmatic Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Antiasthmatic Drug Consumption Value Comparison
4.2.1 United States VS China: Antiasthmatic Drug Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Antiasthmatic Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Antiasthmatic Drug Companies and Market Share, 2019-2024
4.3.1 United States Based Antiasthmatic Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antiasthmatic Drug Revenue, (2019-2024)
4.4 China Based Companies Antiasthmatic Drug Revenue and Market Share, 2019-2024
4.4.1 China Based Antiasthmatic Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antiasthmatic Drug Revenue, (2019-2024)
4.5 Rest of World Based Antiasthmatic Drug Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Antiasthmatic Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Antiasthmatic Drug Revenue, (2019-2024)
5.1 World Antiasthmatic Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Bronchodilators
5.2.2 Anti-allergic Antiasthmatic
5.2.3 Anti-inflammatory Antiasthmatic
5.3 Market Segment by Type
5.3.1 World Antiasthmatic Drug Market Size by Type (2019-2024)
5.3.2 World Antiasthmatic Drug Market Size by Type (2025-2030)
5.3.3 World Antiasthmatic Drug Market Size Market Share by Type (2019-2030)
6.1 World Antiasthmatic Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Antiasthmatic Drug Market Size by Application (2019-2024)
6.3.2 World Antiasthmatic Drug Market Size by Application (2025-2030)
6.3.3 World Antiasthmatic Drug Market Size by Application (2019-2030)
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Antiasthmatic Drug Product and Services
7.1.4 Novartis AG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Details
7.2.2 GlaxoSmithKline Major Business
7.2.3 GlaxoSmithKline Antiasthmatic Drug Product and Services
7.2.4 GlaxoSmithKline Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 ABC Farmaceutici Spa
7.3.1 ABC Farmaceutici Spa Details
7.3.2 ABC Farmaceutici Spa Major Business
7.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Product and Services
7.3.4 ABC Farmaceutici Spa Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 ABC Farmaceutici Spa Recent Developments/Updates
7.3.6 ABC Farmaceutici Spa Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Antiasthmatic Drug Product and Services
7.4.4 AstraZeneca Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Teva Pharmaceutical Industries Ltd
7.5.1 Teva Pharmaceutical Industries Ltd Details
7.5.2 Teva Pharmaceutical Industries Ltd Major Business
7.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product and Services
7.5.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.5.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.6 Mundipharma Pharmaceuticals Ltd.
7.6.1 Mundipharma Pharmaceuticals Ltd. Details
7.6.2 Mundipharma Pharmaceuticals Ltd. Major Business
7.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product and Services
7.6.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Mundipharma Pharmaceuticals Ltd. Recent Developments/Updates
7.6.6 Mundipharma Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
7.7 MSD
7.7.1 MSD Details
7.7.2 MSD Major Business
7.7.3 MSD Antiasthmatic Drug Product and Services
7.7.4 MSD Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 MSD Recent Developments/Updates
7.7.6 MSD Competitive Strengths & Weaknesses
7.8 Daiichi Sankyo Company Limited
7.8.1 Daiichi Sankyo Company Limited Details
7.8.2 Daiichi Sankyo Company Limited Major Business
7.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Product and Services
7.8.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Daiichi Sankyo Company Limited Recent Developments/Updates
7.8.6 Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
7.9 Chiesi GmbH
7.9.1 Chiesi GmbH Details
7.9.2 Chiesi GmbH Major Business
7.9.3 Chiesi GmbH Antiasthmatic Drug Product and Services
7.9.4 Chiesi GmbH Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Chiesi GmbH Recent Developments/Updates
7.9.6 Chiesi GmbH Competitive Strengths & Weaknesses
7.10 Kyorin Pharmaceutical Co.,Ltd.
7.10.1 Kyorin Pharmaceutical Co.,Ltd. Details
7.10.2 Kyorin Pharmaceutical Co.,Ltd. Major Business
7.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product and Services
7.10.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.10.6 Kyorin Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Kissei Pharmaceutical Co.Ltd.
7.11.1 Kissei Pharmaceutical Co.Ltd. Details
7.11.2 Kissei Pharmaceutical Co.Ltd. Major Business
7.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Services
7.11.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Kissei Pharmaceutical Co.Ltd. Recent Developments/Updates
7.11.6 Kissei Pharmaceutical Co.Ltd. Competitive Strengths & Weaknesses
7.12 Ruiyang Pharmaceutical Co., Ltd
7.12.1 Ruiyang Pharmaceutical Co., Ltd Details
7.12.2 Ruiyang Pharmaceutical Co., Ltd Major Business
7.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
7.12.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Ruiyang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Fuhe Group
7.13.1 Fuhe Group Details
7.13.2 Fuhe Group Major Business
7.13.3 Fuhe Group Antiasthmatic Drug Product and Services
7.13.4 Fuhe Group Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Fuhe Group Recent Developments/Updates
7.13.6 Fuhe Group Competitive Strengths & Weaknesses
7.14 Lunan Pharmaceutical Group Co., Ltd
7.14.1 Lunan Pharmaceutical Group Co., Ltd Details
7.14.2 Lunan Pharmaceutical Group Co., Ltd Major Business
7.14.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product and Services
7.14.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments/Updates
7.14.6 Lunan Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
7.15 Chengdu Huayu Pharmaceutical Co., Ltd
7.15.1 Chengdu Huayu Pharmaceutical Co., Ltd Details
7.15.2 Chengdu Huayu Pharmaceutical Co., Ltd Major Business
7.15.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
7.15.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments/Updates
7.15.6 Chengdu Huayu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.16 Kaifeng Kangnuo Pharmaceutical Co., Ltd
7.16.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Details
7.16.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Major Business
7.16.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
7.16.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 Kaifeng Kangnuo Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Akorn Pharmaceutical Co.Ltd.
7.17.1 Akorn Pharmaceutical Co.Ltd. Details
7.17.2 Akorn Pharmaceutical Co.Ltd. Major Business
7.17.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Services
7.17.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Akorn Pharmaceutical Co.Ltd. Recent Developments/Updates
7.17.6 Akorn Pharmaceutical Co.Ltd. Competitive Strengths & Weaknesses
7.18 Boehringer Ingelheim Pharma GmbH&Co.KG
7.18.1 Boehringer Ingelheim Pharma GmbH&Co.KG Details
7.18.2 Boehringer Ingelheim Pharma GmbH&Co.KG Major Business
7.18.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product and Services
7.18.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments/Updates
7.18.6 Boehringer Ingelheim Pharma GmbH&Co.KG Competitive Strengths & Weaknesses
7.19 Covis Pharmaceutical Inc
7.19.1 Covis Pharmaceutical Inc Details
7.19.2 Covis Pharmaceutical Inc Major Business
7.19.3 Covis Pharmaceutical Inc Antiasthmatic Drug Product and Services
7.19.4 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Covis Pharmaceutical Inc Recent Developments/Updates
7.19.6 Covis Pharmaceutical Inc Competitive Strengths & Weaknesses
7.20 Roche
7.20.1 Roche Details
7.20.2 Roche Major Business
7.20.3 Roche Antiasthmatic Drug Product and Services
7.20.4 Roche Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 Roche Recent Developments/Updates
7.20.6 Roche Competitive Strengths & Weaknesses
8.1 Antiasthmatic Drug Industry Chain
8.2 Antiasthmatic Drug Upstream Analysis
8.3 Antiasthmatic Drug Midstream Analysis
8.4 Antiasthmatic Drug Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Antiasthmatic Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Antiasthmatic Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Antiasthmatic Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Antiasthmatic Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Antiasthmatic Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antiasthmatic Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Antiasthmatic Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Antiasthmatic Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Antiasthmatic Drug Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Antiasthmatic Drug Players in 2023
Table 12. World Antiasthmatic Drug Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Antiasthmatic Drug Company Evaluation Quadrant
Table 14. Head Office of Key Antiasthmatic Drug Player
Table 15. Antiasthmatic Drug Market: Company Product Type Footprint
Table 16. Antiasthmatic Drug Market: Company Product Application Footprint
Table 17. Antiasthmatic Drug Mergers & Acquisitions Activity
Table 18. United States VS China Antiasthmatic Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Antiasthmatic Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Antiasthmatic Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antiasthmatic Drug Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Antiasthmatic Drug Revenue Market Share (2019-2024)
Table 23. China Based Antiasthmatic Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antiasthmatic Drug Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Antiasthmatic Drug Revenue Market Share (2019-2024)
Table 26. Rest of World Based Antiasthmatic Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Antiasthmatic Drug Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Antiasthmatic Drug Revenue Market Share (2019-2024)
Table 29. World Antiasthmatic Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Antiasthmatic Drug Market Size by Type (2019-2024) & (USD Million)
Table 31. World Antiasthmatic Drug Market Size by Type (2025-2030) & (USD Million)
Table 32. World Antiasthmatic Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Antiasthmatic Drug Market Size by Application (2019-2024) & (USD Million)
Table 34. World Antiasthmatic Drug Market Size by Application (2025-2030) & (USD Million)
Table 35. Novartis AG Basic Information, Area Served and Competitors
Table 36. Novartis AG Major Business
Table 37. Novartis AG Antiasthmatic Drug Product and Services
Table 38. Novartis AG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Novartis AG Recent Developments/Updates
Table 40. Novartis AG Competitive Strengths & Weaknesses
Table 41. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 42. GlaxoSmithKline Major Business
Table 43. GlaxoSmithKline Antiasthmatic Drug Product and Services
Table 44. GlaxoSmithKline Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. GlaxoSmithKline Recent Developments/Updates
Table 46. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 47. ABC Farmaceutici Spa Basic Information, Area Served and Competitors
Table 48. ABC Farmaceutici Spa Major Business
Table 49. ABC Farmaceutici Spa Antiasthmatic Drug Product and Services
Table 50. ABC Farmaceutici Spa Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. ABC Farmaceutici Spa Recent Developments/Updates
Table 52. ABC Farmaceutici Spa Competitive Strengths & Weaknesses
Table 53. AstraZeneca Basic Information, Area Served and Competitors
Table 54. AstraZeneca Major Business
Table 55. AstraZeneca Antiasthmatic Drug Product and Services
Table 56. AstraZeneca Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. AstraZeneca Recent Developments/Updates
Table 58. AstraZeneca Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Industries Ltd Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceutical Industries Ltd Major Business
Table 61. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product and Services
Table 62. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 65. Mundipharma Pharmaceuticals Ltd. Basic Information, Area Served and Competitors
Table 66. Mundipharma Pharmaceuticals Ltd. Major Business
Table 67. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product and Services
Table 68. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Mundipharma Pharmaceuticals Ltd. Recent Developments/Updates
Table 70. Mundipharma Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
Table 71. MSD Basic Information, Area Served and Competitors
Table 72. MSD Major Business
Table 73. MSD Antiasthmatic Drug Product and Services
Table 74. MSD Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. MSD Recent Developments/Updates
Table 76. MSD Competitive Strengths & Weaknesses
Table 77. Daiichi Sankyo Company Limited Basic Information, Area Served and Competitors
Table 78. Daiichi Sankyo Company Limited Major Business
Table 79. Daiichi Sankyo Company Limited Antiasthmatic Drug Product and Services
Table 80. Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 82. Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
Table 83. Chiesi GmbH Basic Information, Area Served and Competitors
Table 84. Chiesi GmbH Major Business
Table 85. Chiesi GmbH Antiasthmatic Drug Product and Services
Table 86. Chiesi GmbH Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Chiesi GmbH Recent Developments/Updates
Table 88. Chiesi GmbH Competitive Strengths & Weaknesses
Table 89. Kyorin Pharmaceutical Co.,Ltd. Basic Information, Area Served and Competitors
Table 90. Kyorin Pharmaceutical Co.,Ltd. Major Business
Table 91. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product and Services
Table 92. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Kyorin Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 94. Kyorin Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 95. Kissei Pharmaceutical Co.Ltd. Basic Information, Area Served and Competitors
Table 96. Kissei Pharmaceutical Co.Ltd. Major Business
Table 97. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Services
Table 98. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Kissei Pharmaceutical Co.Ltd. Recent Developments/Updates
Table 100. Kissei Pharmaceutical Co.Ltd. Competitive Strengths & Weaknesses
Table 101. Ruiyang Pharmaceutical Co., Ltd Basic Information, Area Served and Competitors
Table 102. Ruiyang Pharmaceutical Co., Ltd Major Business
Table 103. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
Table 104. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Ruiyang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 106. Ruiyang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 107. Fuhe Group Basic Information, Area Served and Competitors
Table 108. Fuhe Group Major Business
Table 109. Fuhe Group Antiasthmatic Drug Product and Services
Table 110. Fuhe Group Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Fuhe Group Recent Developments/Updates
Table 112. Fuhe Group Competitive Strengths & Weaknesses
Table 113. Lunan Pharmaceutical Group Co., Ltd Basic Information, Area Served and Competitors
Table 114. Lunan Pharmaceutical Group Co., Ltd Major Business
Table 115. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product and Services
Table 116. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Lunan Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 118. Lunan Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
Table 119. Chengdu Huayu Pharmaceutical Co., Ltd Basic Information, Area Served and Competitors
Table 120. Chengdu Huayu Pharmaceutical Co., Ltd Major Business
Table 121. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
Table 122. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 124. Chengdu Huayu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 125. Kaifeng Kangnuo Pharmaceutical Co., Ltd Basic Information, Area Served and Competitors
Table 126. Kaifeng Kangnuo Pharmaceutical Co., Ltd Major Business
Table 127. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product and Services
Table 128. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments/Updates
Table 130. Kaifeng Kangnuo Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 131. Akorn Pharmaceutical Co.Ltd. Basic Information, Area Served and Competitors
Table 132. Akorn Pharmaceutical Co.Ltd. Major Business
Table 133. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product and Services
Table 134. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Akorn Pharmaceutical Co.Ltd. Recent Developments/Updates
Table 136. Akorn Pharmaceutical Co.Ltd. Competitive Strengths & Weaknesses
Table 137. Boehringer Ingelheim Pharma GmbH&Co.KG Basic Information, Area Served and Competitors
Table 138. Boehringer Ingelheim Pharma GmbH&Co.KG Major Business
Table 139. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product and Services
Table 140. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments/Updates
Table 142. Boehringer Ingelheim Pharma GmbH&Co.KG Competitive Strengths & Weaknesses
Table 143. Covis Pharmaceutical Inc Basic Information, Area Served and Competitors
Table 144. Covis Pharmaceutical Inc Major Business
Table 145. Covis Pharmaceutical Inc Antiasthmatic Drug Product and Services
Table 146. Covis Pharmaceutical Inc Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Covis Pharmaceutical Inc Recent Developments/Updates
Table 148. Roche Basic Information, Area Served and Competitors
Table 149. Roche Major Business
Table 150. Roche Antiasthmatic Drug Product and Services
Table 151. Roche Antiasthmatic Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 152. Global Key Players of Antiasthmatic Drug Upstream (Raw Materials)
Table 153. Antiasthmatic Drug Typical Customers
List of Figure
Figure 1. Antiasthmatic Drug Picture
Figure 2. World Antiasthmatic Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Antiasthmatic Drug Total Market Size (2019-2030) & (USD Million)
Figure 4. World Antiasthmatic Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Antiasthmatic Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Antiasthmatic Drug Revenue (2019-2030) & (USD Million)
Figure 13. Antiasthmatic Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 16. World Antiasthmatic Drug Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. China Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. India Antiasthmatic Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Antiasthmatic Drug by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiasthmatic Drug Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiasthmatic Drug Markets in 2023
Figure 27. United States VS China: Antiasthmatic Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Antiasthmatic Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Antiasthmatic Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Antiasthmatic Drug Market Size Market Share by Type in 2023
Figure 31. Bronchodilators
Figure 32. Anti-allergic Antiasthmatic
Figure 33. Anti-inflammatory Antiasthmatic
Figure 34. World Antiasthmatic Drug Market Size Market Share by Type (2019-2030)
Figure 35. World Antiasthmatic Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Antiasthmatic Drug Market Size Market Share by Application in 2023
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Other
Figure 40. Antiasthmatic Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis AG GlaxoSmithKline ABC Farmaceutici Spa AstraZeneca Teva Pharmaceutical Industries Ltd Mundipharma Pharmaceuticals Ltd. MSD Daiichi Sankyo Company Limited Chiesi GmbH Kyorin Pharmaceutical Co.,Ltd. Kissei Pharmaceutical Co.Ltd. Ruiyang Pharmaceutical Co., Ltd Fuhe Group Lunan Pharmaceutical Group Co., Ltd Chengdu Huayu Pharmaceutical Co., Ltd Kaifeng Kangnuo Pharmaceutical Co., Ltd Akorn Pharmaceutical Co.Ltd. Boehringer Ingelheim Pharma GmbH&Co.KG Covis Pharmaceutical Inc Roche
Related Reports
11 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
